updates in cll from eha 2024: combinations of btk and bcl2 inhibitors, btk degraders, and more
Published 1 month ago • 398 plays • Length 11:55Download video MP4
Download video MP3
Similar videos
-
1:45
the importance of real-world data in cll & efficacy of btk and bcl-2 inhibitors in the real world
-
3:46
latest updates in the cll treatment landscape
-
42:14
highlights from eha 2024 - updates on the treatment of cll
-
4:13
front-line and r/r updates in cll from eha
-
1:28
the future of cll treatment
-
46:18
eha 2024 - updates on cll with dr. banerji, dr. assouline, and dr. hillis
-
0:53
the future of cll treatment
-
1:30
exciting new agents in cll
-
6:35
2024-08-18
-
16:14
clinical clip from eha 2024
-
5:06
evolution of btk inhibitors in cll
-
1:33
future advancements in the treatment of cll
-
1:32
an update from bellwave-001: nemtabrutinib in cll/sll
-
1:03
cll trial updates from eha 2022
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
51:26
updates in cll - 2023 best of hematology conference
-
1:22
the future of cll treatment and more personalized approaches
-
1:21
how the concept of fitness in cll has changed with the introduction of novel targeted agents
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
2:26
outcomes of ven-based regimens in cll/sll following intolerance or progression on covalent btki's
-
5:51
major cll updates from eha 2019
-
0:44
updates at ash in cll: u2